Investigation about treatment of midnight hypertension in diabetes

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2009
INTERVENTION: olmesartan 20 mg +amlodipine 5mg once daily olmesartan 20 mg + azelnidipine 16 mg once daily candesartan 8 mg or varsartan 80 mg + amlodipine 5mg once daily candesartan 8 mg or varsartan 80 mg + azelnidipine 16 mg once daily CONDITION: hypertension in diabetes PRIMARY OUTCOME: comparison of the anti‐hypertensive effect through the 24 hrs SECONDARY OUTCOME: change in urinary albumin excretion ratio INCLUSION CRITERIA: diabetes patient having midnight hypertension
Epistemonikos ID: 276c5fbbc81eee391ace462d05e48c890439ebca
First added on: Aug 22, 2024